Prolonged Disease-Free Survival by Maintenance Chemotherapy among Patients with Recurrent Platinum-Sensitive Ovarian Cancer
- 30 November 1998
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 71 (2), 190-195
- https://doi.org/10.1006/gyno.1998.5112
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Continued Chemosensitivity to Cisplatin/Carboplatin in Ovarian Carcinoma Despite Treatment with Multiple Prior Platinum-Based RegimensGynecologic Oncology, 1997
- Treatment of recurrent ovarian cancer: increasing options--"recurrent" results.Journal of Clinical Oncology, 1997
- Second‐line chemotherapy for recurrent carcinoma of the ovaryCancer, 1993
- The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: “Maintenance” therapy reconsideredGynecologic Oncology, 1992
- Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.Journal of Clinical Oncology, 1991
- Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.Journal of Clinical Oncology, 1991
- 1.5-5 Years of uninterrupted cis-diamminedichloroplatinum II chemotherapy for metastatic cervical cancerGynecologic Oncology, 1987
- AnnouncementGynecologic Oncology, 1986
- Recurrent ovarian carcinoma: Retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agentGynecologic Oncology, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958